Results 241 to 250 of about 22,485 (285)

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

Arthritis and Rheumatism, 2002
Peter A Merkel, Richard W Martin
exaly  

Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials

Annals of the Rheumatic Diseases, 2013
Matthieu Roustit, Sophie Blaise, Yannick Allanore   +2 more
exaly  

ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon

Vasa - European Journal of Vascular Medicine, 2017
Faisel Khan, Christian Heiss, Anders Gottsäter   +2 more
exaly  

The Prognostic Value of Nailfold Capillary Changes for the Development of Connective Tissue Disease in Children and Adolescents with Primary Raynaud Phenomenon: A Follow‐up Study of 250 Patients

, 2006
Slavica Pavlov‐Dolijanović, Nemanja Damjanov, Predrag Ostojić, Gordana Sušić, R Stojanović, Dragica Gacić, Aleksandra Grdinić   +6 more
openalex   +1 more source

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Arthritis and Rheumatology, 2017
Christopher P Denton
exaly  

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

Arthritis and Rheumatism, 2001
Beverley Shea, Vivian Welch, Janet E Pope   +2 more
exaly  

Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis

Arthritis and Rheumatism, 2011
Ariane Herrick, Frank H J Van Den Hoogen
exaly  

Raynaud's Disease

2007
openaire   +1 more source

The pathogenesis, diagnosis and treatment of Raynaud phenomenon

Nature Reviews Rheumatology, 2012
Ariane Herrick
exaly  

[Raynaud's syndrome, Raynaud's disease].

Ryoikibetsu shokogun shirizu, 1997
openaire   +1 more source